Intravascular ultrasound for Syndrome

Waitlist Available · 18+ · Female · New York, NY

This study is evaluating whether a set of activities can improve blood flow to the heart in women with heart attacks.

See full description

About the trial for Syndrome

Eligible Conditions
Acute Coronary Syndrome · Syndrome · Acute Coronary Syndrome (ACS) · Coronary Artery Disease · Coronary Disease · Myocardial Ischemia

Treatment Groups

This trial involves 2 different treatments. Intravascular Ultrasound is the primary treatment being studied. Participants will all receive the same treatment. There is no placebo group. The treatments being tested are not being studied for commercial purposes.

Main TreatmentA portion of participants receive this new treatment to see if it outperforms the control.
Intravascular ultrasound
Control TreatmentAnother portion of participants receive the standard treatment to act as a baseline.

About The Treatment

First Studied
Drug Approval Stage
How many patients have taken this drug
Completed Phase 2
Intravascular ultrasound


This trial is for female patients aged 18 and older. There are 3 eligibility criteria to participate in this trial as listed below.

Inclusion & Exclusion Checklist
Mark “yes” if the following statements are true for you:
positive cardiac markers and/or ST elevation
scheduled for angiography
View All
Odds of Eligibility
Be sure to apply to 2-3 other trials, as you have a low likelihood of qualifying for this one.Apply To This Trial
Similar Trials

Approximate Timelines

Please note that timelines for treatment and screening will vary by patient
Screening: ~3 weeks
Treatment: varies
Reporting: within one week of enrollment
Screening: ~3 weeks
Treatment: Varies
Reporting: within one week of enrollment
This trial has approximate timelines as follows: 3 weeks for initial screening, variable treatment timelines, and reporting: within one week of enrollment.
View detailed reporting requirements
Trial Expert
Connect with the researchersHop on a 15 minute call & ask questions about:
- What options you have available- The pros & cons of this trial
- Whether you're likely to qualify- What the enrollment process looks like

Measurement Requirements

This trial is evaluating whether Intravascular ultrasound will improve 1 primary outcome in patients with Syndrome. Measurement will happen over the course of within one week of enrollment.

IVUS and MRI findings

Patient Q & A Section

Please Note: These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What are common treatments for syndrome?

Syndromes such as panic disorder and somatization syndrome often respond poorly to conventional treatment with antidepressants alone. While CBT is used effectively as first-line therapy for such syndromes, it is typically used as a second-line procedure until the patient's symptoms have stabilized.

Anonymous Patient Answer

How many people get syndrome a year in the United States?

Significant differences between racial and ethnic groups in syndromic cancer prevalence and incidence suggest differing risk factors or pathogenesiologic factors. Knowledge of the annual incidence of non-syndromic malignancy and of the incidence of syndromic malignancies in specific racial or ethnic groups should enable prevention and intervention measures to be tailored to these groups.

Anonymous Patient Answer

What causes syndrome?

The cause of syndrome may be similar to a symptom; however, there are no biological abnormalities that are present in all affected people. Syndromes can be secondary to many serious health problems such as cancers, multiple sclerosis, and infection. The disease hypothesis of arthritis and depression does not appear to be compatible with the syndrome concept of IBS, fibromyalgia, or functional somatic symptom disorder. It is important for clinicians to remember the need to consider all possible underlying causes of the presenting complaint.

Anonymous Patient Answer

What is syndrome?

The syndrome is the result of a complex interplay between the environment and the individual, and the syndrome is a clinical diagnosis. The syndrome is not a 'disease'. The purpose of syndrome analysis is to make a diagnosis and to develop specific plans, which should be in accordance with the individual's strengths and needs. You can find the clinical trials from the Australian Clinical Trials Register. For a good understanding of the syndrome and its treatment, you can look at the [DOPPS' clinical trials guidelines. For the treatment of chronic conditions, the [European guideline and the American guideline for state clinical trials] are good information sources.

Anonymous Patient Answer

What are the signs of syndrome?

The signs of syndrome are: obesity, infertility, low testosterone and elevated prolactin levels. Symptoms can appear soon after birth and are usually permanent. The signs and symptoms of diabetes or obesity must be differentiated from those of syndromic obesity. Syndromes such as diabetes and polycystic lipodystrophy can be diagnosed by clinical examination with a comprehensive biochemistry. Some signs can be identified in adolescence or adulthood and are the hallmark of syndromic obesity.

Anonymous Patient Answer

Can syndrome be cured?

Syndromes are not necessarily reversible, nor do they have to be cured in order for an individual to grow and function in society. Syndromes can also bring great comfort to an individual as they help to cope with adversity and may also add color to an individual's life. Furthermore, an emphasis on diagnosis and management of syndromes, and not on curing them, can greatly assist in helping individuals overcome adversity.

Anonymous Patient Answer

What is the primary cause of syndrome?

Two of the four primary categories were as follows: a combination of hereditary anomalies caused by specific single-gene mutations, congenital syndromes associated with specific environmental exposures, and syndromes acquired after embryogenesis. The combination of congenital and acquired syndromes is highly indicative of their true etiology.

Anonymous Patient Answer

Does intravascular ultrasound improve quality of life for those with syndrome?

Symptomatic carotid artery disease has a negative impact on the quality of life even in low-risk patients. It leads to a substantial reduction in quality of life in a significant proportion of patients.

Anonymous Patient Answer

Have there been any new discoveries for treating syndrome?

The most promising therapies for treating anosmia are in the research and development phases. Currently, there are no therapies which have been proven to treat this condition. In cases where anosmia does relate to a certain entity, such as central nervous system diseases, treatment must be guided by a neurologist in order to determine the underlying cause and choose the best available therapy. The only available treatment for anosmia with a known identifiable cause is surgical intervention, for instance a tympanoplasty or chorda tympani graft. However, in many cases, the only treatment is symptomatic and supportive. Thus, the field of anosmia research has proven difficult and continues to be highly varied.

Anonymous Patient Answer

Have there been other clinical trials involving intravascular ultrasound?

There have been several previous, small nonrandomized trials using intravascular ultrasound. Although these studies have not been conclusive, there is a reasonable suggestion that statin therapy has a possible role in the prevention or treatment of intimal thickening. Because intravascular ultrasound has emerged as a reproducible methodology with no serious adverse events to date, multiple observational study designs are now in place by several independent groups. If the safety profile of percutaneous and surgical interventions remains positive, there seems a reasonable strategy for implementing randomized clinical trials of this technique in the near term.

Anonymous Patient Answer

Is intravascular ultrasound typically used in combination with any other treatments?

[Intravascular ultrasound was used with a high percentage of patients with cardiovascular disease with other treatment modalities, including aspirin. Further research into the effects of intravascular ultrasound on cardiovascular disease is necessary.

Anonymous Patient Answer

What is the average age someone gets syndrome?

More research is required to make an accurate estimation of how many people will be diagnosed with FHL between the ages of 5 and 45. There is no evidence suggesting that younger people will benefit from an aggressive treatment regimen sooner as opposed to later in their lives.

Anonymous Patient Answer
See if you qualify for this trial
Get access to this novel treatment for Syndrome by sharing your contact details with the study coordinator.